Effect of discontinuing of laronidase in a patient with mucopolysaccharidosis type I

J Inherit Metab Dis. 2006 Feb;29(1):230-1. doi: 10.1007/s10545-006-0237-8.

Abstract

We present a patient on enzyme replacement therapy who showed rapid deterioration when laronidase was discontinued owing to pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Humans
  • Iduronidase / therapeutic use*
  • Mucopolysaccharidosis I / drug therapy*
  • Pregnancy
  • Pregnancy Complications
  • Pregnancy Outcome
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Iduronidase